Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Nader S. Jallad"'
Publikováno v:
American Journal of Therapeutics. 3:441-453
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eeca3b2848dc3f820ddc62b250617a98
https://doi.org/10.1097/00045391-199606000-00008
https://doi.org/10.1097/00045391-199606000-00008
Autor:
Nader S. Jallad, Donna J. Mills, Jacqueline de Silva, Michael S. Willett, F. Wilford Germino, Daniel David, Susan M. Weidner
Publikováno v:
American journal of therapeutics. 2(10)
OBJECTIVE: Cough frequency and severity with fosinopril and enalapril were assessed in hypertensive patients with previous angiotensin-converting enzyme inhibitor (ACEI)-associated cough. DESIGN: Prospective, multicenter, randomized, 8-week double-bl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e3101a3f91778d315dbb19cd36d730f
https://pubmed.ncbi.nlm.nih.gov/11854791
https://pubmed.ncbi.nlm.nih.gov/11854791
Autor:
Arthur Stokes, Nader S. Jallad, Adesh K. Jain, Joseph Codispoti, Donald J. Weidler, Charles McNally, Harold W. Schnaper, Phillip D. Toth, Charles L. Curry, Keith C. Ferdinand
Publikováno v:
Journal of clinical pharmacology. 35(1)
A low dose (1.25 mg) of indapamide (Lozol®, Rhone-Poulenc Rorer Pharmaceuticals, Collegeville, PA) was evaluated in 222 elderly patients (≥50 years) with mild to moderate essential hypertension in a multicenter, randomized, double-blind, parallel-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adc59db3e12753e4d1a03daf51ef875b
https://pubmed.ncbi.nlm.nih.gov/7751412
https://pubmed.ncbi.nlm.nih.gov/7751412
Publikováno v:
Journal of clinical pharmacology. 30(1)
The elderly are likely candidates to receive analgesics for pain from a variety of etiologies. Ketorolac tromethamine is a nonsteroidal, analgesic, anti-inflammatory, antipyretic investigational drug with anti-prostaglandin synthetase activity. Sixte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac18e0fc8bd431680798008d749dad6e
https://pubmed.ncbi.nlm.nih.gov/2303585
https://pubmed.ncbi.nlm.nih.gov/2303585
Autor:
Nader S. Jallad
Publikováno v:
The Journal of Clinical Pharmacology. 32:603-603
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ec42f732c3e94a10856af61672e9389
https://doi.org/10.1002/j.1552-4604.1992.tb05767.x
https://doi.org/10.1002/j.1552-4604.1992.tb05767.x
Publikováno v:
British Journal of Clinical Pharmacology. 21:63S-67S
The antihypertensive effect of doxazosin 1-16 mg once-daily was compared with that of atenolol 50-100 mg once-daily, and placebo, utilizing a double-blind parallel group (12 patients each) design. Blood pressure (BP) and pulse rate were determined in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1af9120d17e7caaa5c474562b456ea2b
https://doi.org/10.1111/j.1365-2125.1986.tb02855.x
https://doi.org/10.1111/j.1365-2125.1986.tb02855.x
Publikováno v:
The Journal of Clinical Pharmacology. 20:543-551
The values of the pharmacokinetic parameters for pentobarbital were determined in 18 cats, 12 of which were subjected to acute ischemic stroke by ligation of the left middle cerebral artery (LMCA). All 18 ats received 50 mg/kg sodium pentobarbital du
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6385eacaa903061951b3d1361123cea2
https://doi.org/10.1002/j.1552-4604.1980.tb02548.x
https://doi.org/10.1002/j.1552-4604.1980.tb02548.x
Publikováno v:
The Journal of Clinical Pharmacology. 28:812-817
Pirmenol is a new orally effective antiarrhythmic agent. Reported are the results of oral administration of pirmenol to six patients (age 48.5 +/- 8.6 years, weight 83 +/- 15 kg) with stable ventricular extrasystoles (PVCs)--average ectopy rate 1040
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1b4a71b20f8cfb3297b276b5ee6ce66
https://doi.org/10.1002/j.1552-4604.1988.tb03221.x
https://doi.org/10.1002/j.1552-4604.1988.tb03221.x
Autor:
Diane M. Dorick, Maria R. Marino, Juan J. Martinez, Dyal C. Garg, Donald J. Weidler, Nader S. Jallad, Michael Dey
Publikováno v:
The Journal of Clinical Pharmacology. 27:885-891
This double-blind, placebo-controlled, four-period cross-over study was undertaken to evaluate the sustained-release characteristics of long-acting propranolol hydrochloride (Inderal LA, Ayerst Laboratories, New York, NY) 60 mg qd, to compare the pha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6d0d09d32fc8c0f0d18c531b1228f51
https://doi.org/10.1002/j.1552-4604.1987.tb05584.x
https://doi.org/10.1002/j.1552-4604.1987.tb05584.x
Publikováno v:
Journal of Cardiovascular Pharmacology. 6:S762-765
A single-blind, placebo-controlled study was conducted to determine the dose-response relationship of guanabenz, administered as single oral doses to patients with mild or moderate hypertension. Twelve hypertensive patients received ascending oral do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddbeafae7aa9fa65fc7d5072a401f1fe
https://doi.org/10.1097/00005344-198400065-00007
https://doi.org/10.1097/00005344-198400065-00007